Category: Rare disease
Biomarker-Driven Research: Transforming Treatments for Rare Cancers Reassessing the classification of rare cancer types Historically, research on rare cancers centered around tumor Read Now 
Focused Monitoring Support for Rare Disease Study A small biotech needed functional support for a Phase III rare disease study. Although a contract
existed between the biotech and a clinical research organization (CRO), the study timelines and budget
had slipped. The biotech hired Catalyst Flex to reverse that trend and ultimately saved ~$1 million. Read Now 
Phase III Rare Disease Study Catalyst Flex Assists Biotech for Research Program A small biotech with limited internal capacity outsourced Read Now 
Rapid Report on Rare Disease Epidemiology Medical writing and RWE expert staff increased operational efficiency Diversity in clinical trials has gained Read Now 
CRO Support for XRad Therapeutics XRad Therapeutics announced first patient dosed in Phase 1a clinical trial of XRD-0394 for metastatic, Read Now 
Rare Disease Day 2020 In advance and support of Rare Disease Day, we’ve been featuring rare diseases throughout the Read Now 
A Spotlight on Noonan Syndrome In advance and support of Rare Disease Day taking place this Saturday, February 29, we Read Now 
A Spotlight on Schwartz-Jampel Syndrome This post is for informational purposes only. Catalyst Flex does not provide treatments for Schwartz-Jampel Read Now 
A Spotlight on Rett Syndrome Rare Disease Day is recognized on the last day of February each year. The main Read Now